Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity (Q60725386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M A O'Donnell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

X Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Han

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

264-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer

4 November 2019

cites work

1 reference

12 December 2020

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

1 reference

12 December 2020

Interferon alpha for the treatment of superficial bladder cancer

1 reference

12 December 2020

Antiproliferative Activities of Interferons Against Human Bladder Carcinoma Cell Lines in Vitro

1 reference

12 December 2020

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

12 December 2020

Intravesical interferon alfa in the treatment of superficial bladder cancer

1 reference

12 December 2020

Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone

1 reference

12 December 2020

Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall

1 reference

12 December 2020

Interferon- α can alter the Lytic Susceptibility of Murine Bladder Transitional Cell Carcinoma (MBT-2) by their Original Poor Specific Cytotoxic Tumor Infiltrating Lymphocytes

1 reference

12 December 2020

Immunomodulatory effect of interferon-α2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladder

1 reference

12 December 2020

Long-term results of intravesical therapy for superficial bladder cancer

1 reference

12 December 2020

Immunotherapeutic alternatives in superficial bladder cancer. Interferon, interleukin-2, and keyhole-limpet hemocyanin

1 reference

12 December 2020

Role of the immune response in BCG for bladder cancer

1 reference

12 December 2020

BCG therapy in superficial bladder tumours--complications and precautions

1 reference

12 December 2020

Interferon-alpha suppresses the capacity of T cells to help antibody production by human B cells

1 reference

12 December 2020

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

12 December 2020

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

12 December 2020

Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes

1 reference

12 December 2020

The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer

1 reference

12 December 2020

Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse

1 reference

12 December 2020

[BCG vs. BCG plus recombinant alpha-interferon 2b in superficial tumors of the bladder]

1 reference

12 December 2020

Antiproliferative effects of bacillus Calmette-Gu�rin and interferon ?2b on human bladder cancer cells in vitro

1 reference

12 December 2020

A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein

1 reference

12 December 2020

Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

1 reference

12 December 2020

Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine

1 reference

12 December 2020

Mig and IP-10: CXC chemokines that target lymphocytes

1 reference

12 December 2020

The genetic reconstruction of BCG as a new immunotherapeutic tool.

1 reference

12 December 2020

Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer

1 reference

12 December 2020

Superficial bladder cancer: the role of interferon-alpha.

1 reference

12 December 2020

IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.

1 reference

12 December 2020

Effects of bacillus Calmette-Guèrin and interferon alpha-2B on cytokine production in human bladder cancer cell lines

1 reference

12 December 2020

BCG immunotherapy of bladder cancer: 20 years on.

1 reference

12 December 2020

10.1046/J.1365-2249.2001.01428.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11207657%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1 reference